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1Chapter
Microorganisms as Alternative 
Sources of New Natural Products
Lucía Ortega Cabello
Abstract
Microbial natural products have become important over the last decades due to 
the ability of bacteria and fungi to subsist in different habitats such as marine and 
extreme environments. Microorganisms are able to synthesize new compounds 
with diverse therapeutic activity equal to or better than the activity of compounds 
already known, thus being promising for the treatment of different diseases such as 
cancer or the solution to health problems such as antibiotic resistance. The produc-
tion of microbial natural compounds can be improved by modifying culture media, 
growing conditions, amplifying gene expression or by co-cultivation techniques, 
which are the major challenges in the industrial production of such compounds.
Keywords: microorganisms, antioxidants, antibiotics, antitumor, polymers
1. Introduction
The lack of effectiveness in current therapeutics using already known com-
pounds has made necessary the rediscovery of natural products, either for obtain-
ing new compounds or modifying their structure to improve their activity, where 
plants are the most popular sources.
However, due to seasonal and environmental conditions that influence their 
production, alternative sources have been searched for. Microorganisms have been 
considered as good alternative sources due to the self-sustainability and controllable 
growth conditions such as carbon source, nitrogen source, pH and temperature 
[1, 2], thus leading to the possibility of discovering new compounds.
In this chapter, we will focus on the uses of microbial secondary metabolites as 
antioxidants, antibiotics, antitumor and polymers from mainly Streptomyces genus, 
which have been important in soil bioremediation and biocatalysis for the obtention 
of enantiopure compounds [3–5].
2. Microorganisms as sources of natural products
Since the discovery of penicillin and streptomycin in 1928 and 1943 respectively 
[6, 7], microorganisms have become fascinating alternative sources because of the 
diversity of natural products with new structures to be elucidated and studied for 
biological activity.
Microorganisms can be found in very extreme environments (soil/marine, high/
low temperature, acid/alkaline) [8], with the isolation of these microorganisms being 
a major challenge to date because there are uncultivable microbes, complicating 
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natural product discovery. To overcome this problem, different techniques have 
been applied such as co-cultivation, as well as exploration of isolation techniques 
on natural habitats [9]. Co-cultivation has attracted attention because it can induce 
the biosynthesis of new compounds [10] such as libertellenone A, B, C and D from 
co-cultivating α-proteobacterium and Libertella sp. [11] and stearidonic acid from 
Rhizobium strain 10II and Ankistrodesmus sp. [12].
Terrestrial fungus and actinobacteria are the most important sources of antimi-
crobials, cytotoxic compounds and antioxidants, among others [13]. However, in 
the last few years, marine environment has attracted attention due to the diversity 
and effectivity of natural products [14], such as apratoxins from cyanobacteria 
from the Lyngbya genus used as cytotoxic agents to induce apoptosis [15], as well as 
salinisporamides isolated from Salinispora tropica with activity against human colon 
carcinoma [16].
3. Antibiotics
The inadequate use of current antibiotics has led to antibiotic resistance, which is a 
global threat because of the adaptation rate of microorganisms [17]. Natural product 
discovery as a potential solution to antibiotic resistance has been important if we recall 
the discovery of penicillin and streptomycin. Nevertheless, actinobacteria isolated from 
soil have already been widely exploited, limiting the search of new antibiotics [18].
Due to the latter, the need to search new microorganisms associated with higher 
life forms or from unknown environments such as marine and extreme ecosys-
tems [19, 20], as well as co-cultivation techniques between antagonists strains 
have been useful [21, 22], as the case of the co-cultivation of a Micromonospora 
sp. with a Rhodococcus strain to enhance the production of keyicin [23], as well 
as the co- cultivation of a marine Pestalotia sp. with an unidentified bacteria to 
obtain pestalone which resulted in high activity against Staphylococcus aureus and 
Enterococcus faecium [24].
Among the examples of marine microbial sources is a Streptomyces strain iso-
lated from a marine sediment in India that produced ala-geninthiocin along with 
val-geninthiocin, geninthiocin and staurosporine; all compounds were found to be 
effective against Staphylococcus aureus and Candida albicans [25]. Another example 
is tetrahydroanthra-γ-pyrone from marine Streptomyces sp. (isolated from Binzhou 
shell island), which presented activity against Bacillus subtilis, Staphylococcus aureus 
and Enterococcus faecalis with a minimum inhibitory concentration (MIC) from 3 to 
46 μg/mL [26].
The presence of metals has been explored to increase the production of anti-
biotics, such as the presence of nickel chloride in the cultivation of Streptomyces 
pratensis (isolated from the east coast of China), which enhanced the production 
of angucycline-type antibiotics, with moderate antimicrobial activity against 
Pseudomonas aeruginosa, Klebsiella pneumonia, Escherichia coli and Staphylococcus 
aureus with a MIC of 16 μg/mL [27]. Other minerals that have been tested to 
increase antimicrobial production on other Streptomyces strains are magnesium, 
calcium, manganese, cobalt, copper and iron salts, where copper sulfate and iron 
chloride resulted in the best induction of antimicrobial biosynthesis [28].
The Micromonospora is a genus of actinobacteria known to produce other 
antibiotics such as aminorifamycins and sporalactams with a good antimicrobial 
activity against Mycobacterium tuberculosis [29], as well as phocoenamicins with a 
potent activity against Staphylococcus aureus and Mycobacterium tuberculosis (MIC 
32–64 μg/mL); the differences in their activity are attributed to different functional 
groups in the macrocyclic core [30].
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Marine fungi have been considered as antibiotic sources such as Penicillum sp. 
(isolated from the coast of China), which produced four new compounds (neoc-
itreoviridin, 10z-isocitreoviridinol, penicillstresseol and isopencillstressol) in 
the presence of cobalt. Penicillstresseol and isopencillstressol presented a MIC of 
0.5 μg/mL against Staphylococcus aureus, followed by 10z-isocitroviridinol with a 
MIC value of 1–4 μg/mL, while neocitreoviridin exhibited a strong activity against 
Pseudomonas aeruginosa with a MIC around 4 μg/mL [31].
Marine Engyodontium album (isolated from a sponge) produced six new 
polyketides, where engyodontochone A and engyodontochone B were the ones that 
exhibited the best antimicrobial activity against Staphylococcus aureus, which was 
better than that of chloramphenicol [32].
Emerimicin IV extracted from Emericellopsis minima (isolated from a bay in 
Chile) exhibited a strong antimicrobial activity against Enterococcus faecalis and 
moderate to low activity against Staphylococcus aureus with a MIC value of 12.5 and 
100 μg/mL respectively [33].
Extremophiles have also been useful in the discovery of new antibiotics due to 
the extreme growth conditions such as salinity (>1.0 M NaCl), pH (<5.0, >8.0), 
temperature (1–15°C and >45°C) and pressure (380 atm and >500–1200 atm); such 
conditions can be found on oceans, hypersaline lakes, hot springs and hydrother-
mal vents, among other places [34]. Actinobacteria are known to survive a range 
of the conditions previously reviewed such as the ones isolated from Kazakhstan 
where screening for antagonistic strains against Escherichia coli and Aspergillus 
niger [35].
Co-cultivation techniques have also been used for antibiotic synthesis such 
as Penicillium fuscum with Penicillium camemberti/clavigerum, whose co-culture 
allowed the extraction and purification of new macrolides named berkeleylactones. 
Berkeleylactone A was the one that exhibited the best activity against Staphylococcus 
aureus, Bacillus anthracis, Streptococcus pyogenes, Candida albicans and Candida 
glabrata [36].
4. Antioxidants
Antioxidants are molecules capable of counteracting at low concentrations the 
damage of mainly reactive oxygen and nitrogen species (ROS and RNS), which 
are generated from metabolic pathways such as mitochondrial respiratory chain 
and lipid β-oxidation among others [37, 38]; depending on the ROS/RNS, they 
can attack different targets [39, 40] whether biomolecules such as proteins, lipids 
and nucleic acids or cell organelles [22, 41]. Usually ROS and RNS at moderate 
concentration are useful for defense, signaling mechanisms and cellular matura-
tion [42–45]; however when ROS and RNS concentration are in excess, differ-
ent pathologies can be caused due to oxidative stress by causing tissue damage 
[41, 43, 45, 46].
In this regard actinobacteria have played their role as potential sources of 
antioxidants where [47] isolated Streptomyces strains in the Oman sea presented an 
inhibitory concentration 50 (IC50) that ranges from 356.8 to 566.4 μg/mL against 
2,2-diphenyl-1-picrylhydrazyl (DPPH) radical inhibition.
Growth media is important for the production of antioxidants such as the case 
reported by [48] on Streptomyces variabilis (isolated from the Gulf of Khambhat) 
using six different media: starch casein agar, yeast malt extract agar (ISP2), glyc-
erol asparagine agar (ISP5), inorganic salt agar (ISP4), tyrosine agar (ISP7) and 
gause’ synthetic agar (GSA), and incubated at 30°C for 7–9 days. GSA medium was 
selected because there was a larger quantity of cell mass compared to other media; 
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its metabolites were extracted with ethyl acetate and antioxidant activity was tested 
against DPPH, metal and hydrogen peroxide (H2O2) radical in a concentration 
range from 0.5 to 2.0 mg/mL. The best radical scavenging activity was against H2O2 
radical (64% of antioxidant activity) at a concentration of 0.5 mg/mL.
Specific radical scavengers can be obtained depending on the microorganism 
such as the strain of Streptomyces antioxidans (isolated in the forest of Tanjung 
Lumpur), in a research reported by [49], which exhibited 79.84% of antioxidant 
activity against superoxide radical at an extract concentration of 1.5 mg/mL; 
most compounds present in the extract were pyrazines, fatty acids and a phenolic 
compound. Similar compounds have been found by [50] in a strain of Streptomyces 
monachensis isolated from a mangrove in Malaysia with an antioxidant activity 
against superoxide radical as well as metal chelating activity of 83.80 and 75.50% 
respectively.
Among other antioxidants found on microorganisms extracted due to their 
possible coloring properties are carotenoid pigments mainly used as vitamins in 
the case of carotenes and xanthophylls, which can be found on bacteria (Gordonia 
rubropertincta), yeast (Blakeslea trispora) and microalgae (Haematococcus 
 pluvialis) [51].
In this regard, 50 carbon atom carotenoids identified as bacterioruberin deriva-
tives have been detected as main pigments of Haloterrigena turkmenica grown in 
halobacterium medium, which were tested with DPPH and ferric reducing antioxi-
dant power (FRAP) assays [52].
As mentioned earlier, growth media can influence in the production of anti-
oxidants. Three yeasts isolated from Brazil were tested in different media. The 
highest carotenoid producer was Rhodotorula mucilaginosa in malt and yeast 
extract medium (MYM) followed by glycerol and corn steep liquor (GCSLM) with 
a biomass production of 13.5 and 7.9 g/L and a carotenoid content of 1068.5 and 
224.8 μg/L respectively.
The authors noticed changes in the carotenoid profile with a higher content of 
β-carotene followed by astaxanthin and lutein in MYM (91.8, 6.9 and 1.3% respec-
tively). With GCSLM, astaxanthin and lutein content increased (23.3 and 71.2% 
respectively) and β-carotene content decreased (71.2%).
This change in the carotenoid profile influenced greatly in the antioxidant activ-
ity where the pigments presented antioxidant activity against DPPH, 2.7 and 14.7% 
for MYM and GCSLM respectively. A similar, yet higher behavior was observed 
with 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and FRAP 
[53]. The increase in antioxidant activity could be due to the increase of xanthophyll 
content since the presence of oxygenated moieties in the carotenoid structures 
increases the antioxidant activity [54].
Similar experiments have been carried out by adding bivalent ions such as fer-
rous, calcium, copper and zinc among others as initiators of the Fenton reaction or 
as cofactors for carotenoid biosynthesis [55–57]. However, in a research reported by 
[58], such behavior was not observed on carotenoid pigments from marine strains 
of Rhodococcus and Gordonia genera (isolated from the Gulf of Mexico). However, 
a change in the carotenoid profile was observed on Rhodococcus sp., which may 
improve the antioxidant activity for two reasons:
1. The increase on the selective carotenoids that may present the best antioxidant 
 activity [58].
2. The possible formation of carotenoid-metal complexes, mainly in the 
 oxygenated groups [59].
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These carotenoids were identified as glycosidic carotenoids; such carotenoid 
extracts demonstrated a better antioxidant activity against DPPH radical (IC50 
of 1.07 and 0.09 μg/mL for Rhodococcus sp. and Gordonia sp. respectively) than 
β-carotene (IC50 of 19.59 μg/mL) [60]. Furthermore, these extracts were compared 
against those reported by [61] where the authors calculated an IC50 of 11.6 and 
9.1 μg/mL for carotenoid extracts from two varieties of Bactris gasipae, presenting a 
better antioxidant activity than the bacterial extracts.
Some of these microbial carotenoid pigments are already commercially available 
for their use as supplement like Lycogen™, which is a carotenoid pigment from 
a mutant strain of Rhodobacter sphaeroides [62], which contains spheroidenone, 
bixin (a carotenoid found on Bixa orellana L.) and hydroxyspheroidenone [63, 
64]. Another pigment that is already available is astaxanthin from microalgae 
Haematococcus pluvialis, whose production cost is estimated at $552/Kg, being 
competitive with synthetic carotenoids ($1000/Kg) [65].
5. Antitumor
Tumoral cells are submitted to high levels of ROS and RNS, manifesting uncon-
trolled proliferation, death evasion, angiogenesis, invasiveness and metastasis, 
causing loss of cellular function due to changes in the DNA [66].
The action of ROS and RNS may trigger different factors that stimulate angiogenic 
processes such as the vascular endothelial growth factor inducing proliferation, migra-
tion and tubule formation [67], as well as the induction of epithelial-mesenchymal 
transition by upregulation of transforming growth factor β [68].
In this regard, antioxidants serve as chemopreventive agents on healthy tissue 
while increasing the damage on cancerous cells; this phenomenon has been studied 
on secondary metabolites of plant origin such as soy isoflavone, and polyphenols 
such as resveratrol and hydroxychalcones [69].
Among microbial compounds that presented a correlation between antitumor 
and antioxidant activity were in extracts of Streptomyces malaysiense with com-
pounds identified as pyrrolizidines and deferoxamine, exhibiting antioxidant as 
well as antitumor activities. Deferoxamine, which is listed in the World Health 
Organization’s List of Essential Medicines, presents antioxidant activity by chelat-
ing iron and antitumoral activities [70].
Another interesting example of antitumoral compounds is an already known 
compound that is widely used for breast cancer stage III and IV treatment, which 
is doxorubicin [71], isolated from a mutant strain of Streptomyces peuceticus. 
Doxorubicin works as a DNA intercalating agent by inhibiting the activity of 
topoisomerase II in DNA replication [72].
Since the 1950s there has been an increase in the interest of studying marine 
microbial sources for drug discovery in the area of anticancer drugs such as tetra-
cenoquinocin and 5-iminoarianciamicina, extracted from Streptomyces sp. in 2010, 
which were effective against human cervical carcinoma HeLa cells and myelogenous 
leukemia LH-60 [73].
A similar case is the research reported by [74], where they isolated 32 strains 
from lagoon sediment in Lagos. The strains were identified mostly as Streptomyces 
and Micromonospora. Nine isolates from Streptomyces genus presented cytotoxic 
activity against human acute myelocytic and promyelocytic leukemia, cervical 
carcinoma, human gastric, breast adenocarcinoma cell lines varying their effective-
ness at a concentration below 1 mg/mL. The compounds present in the extracts 
were identified as kigamicin and staurosporine analogues.
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Other kind of compounds found in Streptomyces strains are pyrrolopyrazines 
(found on Streptomyces colonosanans), which presented anticancer activity against 
human colon cancer cell lines [75].
Diketopiperazines from Streptomyces nigra (isolated from a mangrove soil) were 
effective against several human cancer-derived cell lines, while with normal cell 
lines they were inactive at a concentration range of 50–100 μg/mL. Other com-
pound found on Streptomyces nigra was β-carboline, which is a compound widely 
found in plants with anticancer activity against a variety of cancer cell lines that act 
inhibitis DNA topoisomerase as well as intercalates in the DNA strands, changing 
the DNA structure; and tamoxifen [76] which is commonly used to control breast 
cancer after chemo and radiotherapy have been applied to the patient.
Another actinobacteria with discovered antitumor activity is Rhodococcus, 
where [77] a Rhodococcus strain was isolated from a contaminated soil. The extract 
exhibited cytotoxic activity against HepG2 and Hela cell line with an IC50 of 33 and 
73 μg/mL respectively.
Another class of compounds that exhibit antitumor properties are polysac-
charides, which inhibit cell growth and induce apoptosis as well as exert a 
synergistic effect with other chemotherapeutical agents such as doxorubicin 
[78], such as that reported on resveratrol [79, 80]. Examples of these kind of 
compounds are exopolysaccharides (EPs) produced by Bacillus mycoides com-
posed of a sugar mixture containing galactose, mannose, glucose and glucuronic 
acid; such EPs exhibited antitumor activity by observing morphological abnor-
malities in HepG2 and Caco-2 cancer cell lines with an IC50 of 138 and 159 μg/mL 
respectively, while on normal cells the IC50 was 245 μg/mL [81]. A similar activity 
was observed with Bacillus licheniformis EP constituted by glucose, galactose, 
fructose, mannose and galacturonic acid on MCF cancer cell lines with an IC50 
value of 840 μg/mL [82].
It can be observed from both Bacillus species that changes in the polysaccharide 
composition may influence the antitumor activity; as observed by [83] in three 
EPs of Streptococcus thermophilus, two of them were mainly composed by mannose, 
while the other contained mainly glucose with a protein moiety. The latter exhibited 
a higher antitumor activity on HepG2 cells with an IC50 of 313.75 μg/mL, while for 
the other two compounds the antitumor activity was below 50%.
Some Trichoderma species are also able to synthesize EP constituted by man-
nose, glucose, galacturonic acid and glucuronic acid with a mannan core, where the 
antitumor activity was more effective on HeLa cells than on MCF-7 cells by arrest-
ing G2/M phase and inducing apoptosis [84].
Fungal endophytes are another kind of microorganisms that could be used 
as alternative sources of bioactive compounds found in plants. Such as taxol (a 
chemotherapeutic), pestalactams and penicestorids. Taxol was discovered initially 
on Taxus brevifolia, and it presents a similar activity as doxorubicin [85]. Another 
example, camphotecin, found commonly on Campotheca acuminata, was also 
found on Fusarium solani. Camphotecin from Fusarium solani was proved to induce 
apoptosis on Vero cells at a concentration of 30 μg/mL for 24 h with a maximum 
apoptosis of 15% [86].
Endophytic fungi are also able to produce EP with antitumor activity. An 
example is Bionectria ochroleuca whose activity was proved to be effective against 
liver, gastric and colon cancer cell lines in a concentration range from 100 to 
450 μg/mL without exhibiting toxicity in healthy cells [87].
Fungal co-cultivation techniques have also been used in the obtention of antitu-
mor compounds. For example, Isaria felina with Aspergillus sulphureus was used for 
obtaining oxirapentyn L, which exhibited antitumor activity at IC50 greater than 
100 μg/mL [88].
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6. Polymers
Biopolymers such as lipopolysaccharides (LPSs), EP and extracellular polymeric 
substances (EPSs) are high-molecular weight substances secreted by microorgan-
isms [89]. In the case of EP, their antitumor properties have been observed in 
some bacteria as well as in endophytic fungi. EPSs are exopolymers, constituted by 
polysaccharides, lipids, proteins and nucleic acids; the composition provides these 
biopolymers unique properties that can be manipulated for a variety of technologi-
cal applications [90].
LPSs from Gram negative bacteria possess a lipid moiety and a glucosamine frac-
tion with phosphate groups to improve membrane stability [91, 92]. Some of these 
LPSs have been studied as flocculating and emulsifying agents; for example, the 
one produced by Trichosporon mycotoxinivorans at a concentration of 8.6 mg/mL was 
able to flocculate kaolin and charcoal with 80 and 78% of efficiency respectively, 
while the emulsifying activity by mixing water and kerosene presented an emulsifi-
cation efficiency of 81% [93].
Another application of LPSs is to enhance the immune response by accelerating 
the maturation of dendritic cells using immobilized LPS nanostructures; compared 
to LPS solutions and LPS monolayers, such structures could be useful in HIV 
patients [94]. In a similar manner, inactivated LPSs from non-sulfur photosynthetic 
bacteria have been used to stimulate immune response [95].
EPs have become important in material science, being useful as storage mol-
ecules, protective capsular layers and as matrix components of biofilms due to their 
water-binding capacity because of hydroxyl and carboxyl groups. EPs can be used 
in drug delivery, enzyme immobilization, tissue engineering, among other uses 
[96], their production depends on composition and growth conditions applied on 
the culture media [97].
EPs from lactic acid bacteria have been used as emulsifiers and viscosifiers 
because of their pseudoplastic rheological behavior; the sugar identified have been 
dextran, reuteran, levan and insulin, pullulan (homopolysaccharides), kefiran and 
hyaluronic acid (heteropolysaccharides) among others depending on the strain 
used to produce EP [98, 99].
An example of this kind of EP is levan produced by Bacillus licheniformis reported 
by [100] where the authors studied its physicochemical properties and concluded its 
utility in stabilizing topical formulations. Other uses that have been studied of levan 
but from Halomonas smyrnensis were on tissue engineering and prosthetics [101].
Hyaluronic acid from Streptococcus equi was compared against kefiran isolated 
from kefir grains (also produced on lactic acid bacteria) demonstrating antioxidant 
and immunostimulatory activities [102].
Marine EPs are mainly heteropolysaccharides composed of pentoses, hexoses, 
aminosugars or uronic acids [103]. The EPs of Pantoea sp. [97] presented wound 
 healing activity by facilitating cell migration on fibroblasts. The EPs of Bacterium 
polaribacter increased 1.42-fold the wound closure at an EP concentration of 1 mg/mL.
EPS in microbial cells aids in the fixation to marine surfaces, thus forming 
biofilm communities though a three-dimensional arrangement in which the cells 
can localize extracellular activities and conduct agonist/antagonist interactions. In 
marine bacteria, EPSs generally contain higher levels of glucuronic and galacturonic 
acids. Among the sugars found on EPSs are glucose, galactose, mannose, fructose, 
rhamnose, uronic acids, N-acetyl-glucosamine and N-acetyl-galactosamine; the 
protein moiety can occur as peptides, aminosugars, glycoproteins, proteoglycans 
and amyloid proteins. Proteins can occur as peptides, aminosugars, glycoproteins, 
proteoglycans and amyloid proteins. Extracellular DNA and extracellular nucleases 
can be found, thus influencing on the physical consistency [90].
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EPS production depend on the presence of divalent cations [90], as it is in the 
case of Bacillus vallismortis; which EPS was better in composition in the presence of 
zinc enhancing the adsorption capacity [104]; while in the presence of the ferric ion 
the EPS production is limited [90].
An application of EPS is in microencapsulation of vitamins to formulate func-
tional foods as demonstrated on Cyanoteche sp. The authors extracted its EPSs and 
made encapsulation tests of vitamin B12 either alone or in the presence of arabic 
gum by spray-drying technique. EPS alone presented a particle diameter of 8 μm 
and when combined with arabic gum the particle diameter was smaller than that of 
EPS alone; both microcapsules presented different release kinetics due to the differ-
ent swelling mechanisms of the EPS [105]. EPS from another Cyanoteche strain was 
found to be useful for controlled delivery of small molecules such as procainamide 
as well as proteins. The authors found out that adding bivalent cations such as Ca2+, 
as well as considering the protein charge, the release kinetics could improve [106].
Other encapsulation studies were performed on the EPSs of Bacillus subtilis in 
the preservation of Lactobacillus plantarum as probiotic, facilitating its survival in 
gastric conditions during co-cultivation of both strains [107].
EPSs have been widely used in sludge treatment for pharmaceutically active 
ingredients removal such as ciprofloxacin as well as sulfonamides. EPS from 
Klebsiella sp. was tested against sulfonamides; the high protein content of EPS 
(mainly tryptophan and tyrosine) is a critical factor in the adsorption of sulfon-
amides for hydrophobic interactions with sulfonamides [108]. The same thing 
happens with ciprofloxacin being important to reach the isoelectric point of the 
protein moiety as well as the use of iron salts to enhance the adsorption of cipro-
floxacin [109–111].
The latter ability of EPSs to adsorb antibiotics needs further studies in order 
to model and improve the kinetics of controlled release dosage forms giving us a 
natural and possible biocompatible alternative material for design of molecular 
pharmaceutical forms.
7.  Challenges and trends in the discovery and development of microbial 
natural products
Even though the plethora of natural products of microbial origin mainly isolated 
from marine and extreme environments is a large field of research, developments in 
technological aspects such as the increase in natural product production for industrial 
scale-up or overcoming the difficulty in isolating microorganisms are needed [112].
Genome mining focused on the activation of silent genes, to search gene clusters 
serving as molecular markers, with complementary informatic tools has been a 
solution [113, 114]. This technique can be used in metabolic engineering, producing 
an heterologous host through genetic engineering, using plasmids or recombinant 
systems using interspaced palindromic repeat, one of the most recent techniques 
applied in genetic engineering [115].
Another trend also used on unculturable microorganisms is the discovery of 
environmental DNA coupled to cosmids for gene expression, which have also been 
used for the selective isolation of biologically active natural products [116].
Search of ideal media and culture conditions have also been a major challenge 
in optimizing the amount of metabolite present on the microorganism, which have 
been developed by either trial and error or statistical design [116]; an example is the 
presence of metallic salts to activate enzymes involved in the biosynthetic route or 
by manipulating temperature, light, aeration and pH [117] as we saw in the obten-
tion throughout the chapter [117].
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Another technique widely observed along the chapter was co-cultivation tech-
nique between bacteria, fungi or in combination to improve metabolite production.
Conventionally organic solvents are often used for natural product extraction, 
which is an important step for industrial scale-up [118, 119]. However, due to the 
health and environmental hazards, alternative extraction techniques have been 
searched for with the purpose of reducing residues and thus environmental impact 
[119, 120]. Among the alternative extraction techniques are ultrasound, microwave, 
enzyme and pulse electric field. The latter techniques have been widely explored 
on plants; nevertheless, on microorganisms, they have been poorly explored, thus 
representing a critical challenge in natural product research [121, 122].
The possibility to expand the research in this regard, is also the search of alterna-
tive solvents such as supercritical fluids, [119, 120], ionic liquids, gas-expanded 
liquids and vegetable oils [121–123].
8. Conclusions
Microbial natural products are a wide research field with much potential to be 
explored, the main goals being:
a. Isolating new microorganisms, being successful in marine as well as 
extreme environments, including genetic diversity studies for unculturable 
microorganisms.
b. Screening of isolates with potential biological activity, by performing extrac-
tions of different polarity to begin the selectivity of compounds.
c. Extraction and purification for identification of active compounds, where new 
extraction techniques can be explored such as supercritical fluids, microwave, 
enzyme, among others to make the discovery process more eco-friendly.
d. Elucidation of action mechanisms of new active compounds through in silico 
studies, for considering the possibility of improving the activity.
e. Improvement of natural compounds production for industrial scale-up, as it 
has already been seen that these are the main challenges and trends through 
alternative techniques such as co-cultivation, genome mining and media 
formulation, the last one being the first approach for production enhancement.
f. Preclinical and clinical trials of microbial natural products with already 
discovered potential activity, to determine biocompatibility and innocuousness 
of compounds such as EPs and EPSs for antitumoral activity as well as tissue 
engineering.
As it can be seen, there is a long way ahead in natural product discovery 
that could solve many health and environmental issues such as antibiotic 
 resistance,  cancer, soil and water contamination, tissue engineering, among other 
contributions.
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